Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
BAN2401 2 Eisai Co., Ltd. APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Crenezumab MABT5102A , RG7412 2 Genentech APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None
Octagam® Intravenous Immunoglobulin, NewGam 2, 2 Octapharma APP and Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease, Mild Cognitive Impairment